A prospective, longitudinal study to assess use of continuous and reactive low-pressure mattresses to reduce pressure ulcer incidence in a pediatric intensive care unit by García Molina, Pablo et al.
32     ostomy wound management®  July 2012 www.o-wm.com
Feature
a Prospective, longitudinal study to  
assess use of Continuous and  
reactive low-pressure mattresses to  
reduce Pressure ulcer Incidence in a  
Pediatric Intensive Care unit
Pablo García-Molina, MSc, PhD(c); Evelin Balaguer-López, MSc; Joan Enric Torra i Bou, RN; 
Adan Álvarez-Ordiales, MSc; Cristina Quesada-Ramos, MSc; and José Verdú-Soriano, PhD
abstract
Pressure between bony prominences and sleep surfaces, as well as pressure from the use of medical devices, put chil-
dren admitted to pediatric intensive care units (PICUs) at risk of developing pressure ulcers (PUs). To assess the effect 
of two pediatric-specific, continuous and reactive low-pressure mattresses on the incidence of PUs, an observational, 
descriptive, prospective, longitudinal (2009–2011) study was conducted among PICU patients. The two pediatric mat-
tresses — one for children weighing between 500 g and 6 Kg and another for children weighing more than 6 Kg — were 
provided to patients at risk for PUs (Braden-Q ≤16, Neonatal Skin Risk Assessment Scale [NSRAS] ≤13, or per nurse 
assessment of clinical need). Between 2009 and 2011, 30 children (13 [43.3%] girls and 17 [56.7%] boys), ages 0 to 10 
years, at risk of developing PUs (NSRAS risk: n = 14 [13.2 ± 3.03] and Braden-Q risk: n = 10 [10.4 ± 2.4]) were placed 
on the study mattresses for a median of 4 (range 1 to 25) days. Primary reasons for PICU admission included disorders 
of the respiratory system (40%), infectious and parasitic diseases (23.3%), and illnesses of the musculoskeletal system 
and connective tissue (10%). All other PU prevention strategies (eg, repositioning, specialty devices) used as part of 
standard care protocols also were implemented. Of the 30 participants, only one (3.3%) (confidence interval [CI] 95% 
= 0.08 –17.2%) developed a nondevice-related PU. No adverse events occurred. A 2008 incidence study in the same 
PICU, before use of these special surfaces, found a cumulative incidence of 20% nondevice-related PUs. The observed 
incidence rate of nonmedical device-related PUs in this high-risk population placed on these mattresses is encouraging 
and warrants future research.
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literature review 
Pressure ulcers (Pus) have always been considered 
an adverse event associated with adulthood and old age. 
However, in recent decades and closely related to the ex-
tension of the use of intensive therapeutic techniques 
such as extracorporeal membrane oxygenation (eCmo), 
high-frequency oscillatory ventilation, and noninva-
sive mechanical ventilation (VmnI) that limit mobil-
ity, pressure in the contact zones increases, resulting in 
tissue ischemia; thus, Pus in the pediatric population DO
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increasingly occur. In an observational study, Zollo et al1 
described a Pu incidence related to devices and support 
surfaces of 26% in a population of 271 children admit-
ted to a PICu. neidig et al’s observational study2 found 
a prevalence of 16.9% of occipital Pus in a population of 
59 children who received cardiac surgery. a retrospective 
study by schmitd et al3 of two cohorts of 32 children found 
a 53% prevalence of Pus in the group of children treated 
with high-frequency mechanical ventilation, compared to 
a prevalence of 12.5% in the control cohort without venti-
lation. In their multisite prospective cohort study involv-
ing 322 patients (ages 21 days to 8 years of age) admitted 
to a PICu, Curley et al4 found a Pu incidence of 27% re-
lated to support surfaces and medical devices. 
In addition, pediatric patients with neurological or 
disabling illnesses (myelomeningocele, congenital my-
opathies, and the like) that involve long periods of im-
mobility or forced positions, as well as patients generally 
cared for at home, also are at risk for Pus.5 
different intensive therapies used in the PICu and the 
medical conditions requiring hospitalization often re-
duce mobility. according to a report from the national 
Pressure ulcer advisory Panel (nPuaP),6 children who 
remain immobile and insensate to the harm caused by 
pressure and the prolonged deformation of tissues be-
tween bony prominences and sleep surfaces or diagnostic 
or therapeutic devices are at higher risk for Pus. In their 
review of the literature, willock et al7 observed that the 
main locations of Pu were the skin area in contact with 
therapeutic devices and sleep surfaces. In their multisite 
prospective evaluation pre- and post intervention study 
in 51 hospitals involving 2820 neonates, lund et al8 ob-
served that higher Pu risk was related to pulsioximeter 
probes, nasogastric tubes, and endotracheal tubes. In 
waterlow’s multi-centered study9 involving 300 children 
ranging from neonates to children aged 16 years, 27.3% 
of Pus were related to medical equipment.
the most frequent locations of Pus differ between 
children and adults. this is mainly due to the fact that 
during the growth process, each age has a different body 
surface area and weight distribution. according to a re-
view of the literature,10 the most common locations of 
Pus in children <3 years old are the occipital area and 
the ears; in children older than 3 years, ulcers on the sa-
crum and heels are most common. In their study, Curley 
et al4 reported that 32% of stage I and stage II Pus ap-
peared on the heads of PICu patients. these anatomical 
locations are also the areas of greatest contact with the 
support or sleep surface (ss) on which they rest. In an 
observational study conducted among 13 healthy chil-
dren ages 10 weeks to 13.5 years, solis et al11 measured 
interface skin pressures and observed a link between the 
body surface area and anatomical locations subject to the 
greatest levels of pressure. For body surface areas >1 m2, 
the pressure was greater at the sacrum than in the occipi-
tal area. In older children, the distribution of Pu loca-
tions becomes more similar to that of adults. 
Pressure management special surfaces (Pmss) — ie, 
mattresses, mattress pads, or cushions — are an essential 
resource both for preventing Pus in patients at risk and 
for improving the treatment outcome of existing ulcers. 
Pmss are designed to redistribute pressure and avoid 
shear in deep tissues between skin and bony prominences 
in order to reduce the pressure on the highest-risk areas.12 
In the last decade, new pediatric Pmss (P-Pmss) 
have been developed with promising results. according 
to a review of the literature,13 no scientific evidence base 
on clinical practice is available to help clinicians choose 
between the different devices available or to help dis-
tinguish various device features. However, adequately 
powered, double-blind, randomized controlled clinical 
studies of these surfaces are not easy to conduct. thus, 
the literature and guidelines contain contradictory and 
sometimes controversial information. mclane et al14 
conducted an analytical, observational study among 54 
healthy children of different ages that measured the pres-
sure between the children’s skin and the surface of five 
different mattresses and local pressure-relief devices: a 
mattress or a standard hospital baby crib, a foam over-
lay, a mattress with an e-gel donut® (Philips respiron-
ics, andover, ma) type cushion, a foam overlay with an 
e-donut® type cushion, and a low-air-loss overlay. the 
authors observed that the combination of a foam mat-
tress with a gel cushion exerted lower pressures on the 
whole of the body than the use of a dynamic low-air-loss 
mattress. However, the study was limited by the fact that 
the low-air-loss mattress could not be used with children 
weighing <22.7 Kg; also,. dynamic Pmss always have 
been associated with the alternating system. Pmss man-
Key Points
• The authors of this study prospectively evaluated 
the incidence of nonmedical device-related pressure 
ulcers (PUs) among patients admitted to a pediatric 
intensive care unit (PICU).
•  One of 30 patients evaluated developed a nondevice- 
related PU on the occiput.
•  The authors are encouraged by these results because 
they compare favorably to their previously document-
ed PU incidence rate.
•  Prospective, randomized, controlled clinical studies 
are warranted.
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ufacturers advise against the use of this system in certain 
groups of children (eg, children with acute spinal cord 
injuries, unstable fractures, thoracic injuries, fractured 
vertebrae and/or cervical traction). moreover, in the case 
of intubated children in the ICu, alternating surfaces are 
not recommended due to the risk of causing hemody-
namic and/or respiratory instability (bronchospasms) 
when the mattresses inflate and deflate the cells (children 
may not be able to respond to this movement).5 
In 2008, members of the nursing group for the im-
provement of quality in pediatrics at the Valencia uni-
versity clinical hospital interested in the subject created 
a Pu epidemiological monitoring system in the pediat-
ric service. a 5-month incidence study15 was conducted 
within this framework. of the 80 participating PICu 
patients, 13 developed at least one Pu. the cumulative 
incidence (defined as the probability that a particular 
adverse event, such as occurrence of a Pu, has occurred 
before a given time) was calculated as 19.4%, with a total 
number of 45 new device- and nondevice-related Pus in 
13 children with or without risk. Category 1 and category 
2 Pus occurred mainly in areas where medical devices 
table 1. Patient demographics and characteristics (2009–2011 group)
n Frecuency (%) Average SD Median
Age
<1 month
1 month to 3 years
3 to 6 years
6 to 10 years
Total
5
22
1
2
30
16.7
73.3
3.3
6.7
100
Pressure ulcer risk assessed
<1 month (NSRAS) 
>1 month (Braden Q)
Total
5
25
30
16.7
83.3
100
13.2 points
10.4 points
3.03
2.4
14
10
Weight
   <1 month
   >1 month
Total
5
25
30
16.7
83.3
100
4.6 Kg
10.3 Kg
2.4
5.5
3.8
10
Mechanical ventilation
CMVa
NIMVb
HFMVc  
18
9
7
60
30
23.3
6.4 days
4.6 days
5.3 days
5.3
4.7
5.3
5
2
4
Medical treatments
Sedation + vasoactive drugs
 Vasoactive drugs
 Sedation only
 Analgesics
 No drugs
15
5
3
4
3
50% of 30
16.7% of 30
10% of 30
13.3% of 30
10% of 30
Nutritional support
Parenteral
Enteral
22
19
73.3% of 30 
63.3% of 30
Medical devices CVCd 
Arterial catheter
Urinary catheter
28
20
22
93.3% of 30
66.7% of 30
73.3% of 30
a: Conventional mechanical ventilation
b: Noninvasive mechanical ventilation
c: High-frequency mechanical ventilation
d: Central venous catheter
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were applied, such as pulsioximeter probes and nasogas-
tric tubes. most category 3 (three, 6.7%) or category 4 
(one, 2.2%) Pus were in an anatomical location (ie, heel, 
sacrum, occipital area, ear) in contact with standard mat-
tresses. the authors’ PICu had no Pmss in 2008; the po-
tential problems revealed the need for research into the 
use of Pmss that met the requirements in terms of safety 
and pediatric suitability for the children at the most risk.
given the results of the incidence study (2008)15 and 
the fact that the authors had no Pmss with specific fea-
tures for pediatric patients, an observational descriptive 
study was conducted to evaluate the effect of the new 
Pmss’s (Carital neo® and Carital Juve®, ceded by the 
company in 2009) on the occurrence of Pus in PICu pa-
tients. this study focuses on the relationship between the 
sleep surface and the development of Pus. wounds that 
may be related to other factors such as use of medical 
devices were not included. 
study goals were two-fold: 1) measure the incidence 
of the new Pmss-related Pus in PICu patients at risk of 
developing Pus with whom the preventive measure being 
assessed was used; and 2) compare the incidence in the 
group of patients studied with an estimated group value 
in a similar population (children with Pu risk).
methods
study design and population. an observational, de-
scriptive, prospective, and longitudinal (2009–2011) study 
was conducted among patients treated at the PICu of the 
Valencia university Clinical Hospital (HCuV), a 415-bed, 
third-level hospital located in Valencia, spain. the PICu 
at this center has a capacity of five beds with an average 
number of admissions (2008 to 2011) of 220 a year.
Inclusion criteria. all patients admitted (with or 
without Pus previous to receiving the new Pmss) to the 
PICu during the study period were considered eligible, 
pending inclusion/exclusion criteria. eligible patients 
were ages 1 day to 10 years old, admitted to the PICu for 
more than 24 hours for whatever reason, at risk of devel-
oping Pus according to the Braden-Q scale (for children 
>1 month old) or the neonatal skin risk assessment 
scale (nsras, for children <1 month old).16,17 
exclusion criteria. Children admitted to the PICu for 
<24 hours, older than 10 years, lacking verbal consent 
from parents for the use of relevant clinical data, and/or 
who had not received the new Pmss were excluded from 
the study. 
ethical issues. For patients meeting these criteria, 
parents were asked for verbal consent for the use of rel-
evant clinical data; it was not necessary to obtain writ-
ten informed consent because no interventions different 
from usual hospital protocol (eg, skin surveillance) were 
performed in accordance with the clinical situation of 
children, and the study was carried out in the framework 
of a university Hospital where Pu surveillance is a key 
quality control activity. when consent was not obtained, 
children were not included in the evaluation. when pa-
tients were eligible for the study mattresses but none 
were available, the children were assigned to the best ex-
isting standard mattresses or another Pmss (different to 
the study object) according to their risk scores, but were 
not included in the study. 
the confidentiality of clinical data was guaranteed in 
accordance with the hospital’s internal rules. In no case 
was any information that might directly or indirectly 
identify a patient included in the databases, in accor-
dance with current legislation in spain (the spanish data 
protection act, law 15/1999, december 13, 1999). Per-
mission from parents to take photographs was obtained 
verbally, and the patients’ anonymity was guaranteed. 
the nursing supervisors and the head of the pediatrics 
service provided authorization for conducting the study.
materials. Patients included in the study were provid-
ed one of the two Pmss for pediatric use manufactured by 
Carital ltd. (Finland) and distributed in spain by smith 
& nephew. the Pmss were classified as continuous and 
reactive low-pressure special surfaces (CrlPss) intended 
for use in high-risk patients, even when alternating sys-
tems are contraindicated (ie, patients with clinical insta-
bility, spinal injury). Carital neo® is designed for use in 
children weighing between 500 g and 6 Kg; the mattress 
measures 65 cm x 35 cm. Carital Juve® may be used in 
children weighing between 6 Kg and 300 Kg; the mattress 
measures 120 cm x 50 cm x 8 cm. the CrlPss utilize 
a specific and patented technology, the Carital air-Float 
system®, which consists of a double air-cell construction 
in the shape of a tunnel (one within the other) that re-
acts to the pressure being supported (ie, weight, shape, 
and patient movement) in three different compartments 
(head, central or trunk section, and extremities). using a 
computerized system, the mattress continuously adjusts 
to achieve a level of pressure in the interface between the 
skin and the mattress and allows the patient to “float” 
over the surface. the CrlPss maintains the same level of 
support in each section, which is different than alternat-
ing air systems, which change the pressure, inflating and 
deflating cells with a prefixed time.18,19
these CrlPss also facilitate care that involves insert-
ing venous catheters, placing X-ray equipment under-
neath the Pmss, transfers, CPr manuevers, and general 
hygiene measures, such as bathing or sheet changes. Fur-
thermore, they can be used as dynamic overlay mattress 
over another static mattress or as a replacement mattress 
on the bed frame itself without affecting the patient’s 
safety or increasing the risk of falls or strangulation be-
tween the bars of the bed.
Procedures. Following admission, the risk of Pu de-
velopment was assessed using the Braden-Q scale (for 
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children >1 month old) and nsras (for children <1 
month of age). Patients with scores ≤16 and ≤13, respec-
tively, were considered at risk.16 If the patient was deemed 
at risk, the appropriate CrlPss (depending on age, weight, 
and size) was assigned by the nurse in charge within 24 to 
48 hours of admission, depending on CrlPss availability. 
the nurses in the unit making the mattress assignments 
were trained in the use of the CrlPss in informal sessions 
by a member of the research team. when the children did 
not need the CrlPss (ie, clinical improvement, risk re-
duction, discharge, death), the unit nurse informed a re-
search team member about removing the CrlPss. after 
patient use, the mattresses were cleaned, disinfected, and 
stored away until needed again.
all patients (with and without CrlPss) also received 
standard Pu prevention measures according to PICu 
procedures, including repositioning if consistent with 
goals of patient care and medically and clinically possible 
(every 3 to 4 hours). Hyperoxygenated fatty acid (linoleic 
acid oil used to hydrate the skin) was applied to at-risk 
areas every 8 hours, daily hygiene was provided, and pro-
tective hydrocellular dressings were applied between the 
skin and the different therapeutic and diagnostic devices.
Variables. Patient variables collected included an-
thropometric (height and weight) data, gender, diagno-
sis and Pu risk score when admitted, length of hospital 
stay, use of vasoactive drugs, parenteral or enteral feed-
ing, and presence of venous central, arterial or urinary 
catheters. extrinsic variables noted in the data collection 
forms included use of mechanical invasive and noninva-
sive ventilation, and high-flux oxygenation (a respiratory 
device that provides an high oxygen pressure). length of 
device use was monitored and recorded. 
outcomes. Patient skin was assessed daily and the 
presence/absence of a Pu noted. 
Pus were described using the four categories proposed 
by the european Pressure ulcer advisory Panel (ePuaP). 
extrinsic factors were noted, along with the presence or 
absence of a medical device in the injured area. the nurse 
responsible for the patient’s care assessed for Pus daily. 
repositioning schedules, the use of local pressure 
management devices (eg, heel support, cushioned type 
of Pmss [latex, foam, viscoelas-
tic, air-alternating or continuous, 
and CrlPss]) were recorded. In 
the 2008 study, the PICu had one 
standard mattress type (latex) and 
two Pmss types: static (foam and 
viscoelastic) and dynamic (one air-
alternating mattress). the study 
conducted 2009–2011 only assessed 
the patients with CrlPss. reason 
for study discontinuation (eg, dis-
charge, death) also was recorded. 
data collection and analysis. all information was re-
corded using a paper instrument and electronic system. 
data were entered into IBm® sPss® statistics 19 data-
base (sPss, Chicago, Il) for analysis. Patients enrolled 
in the study but not assigned to a CrlPss in accordance 
with the procedure were excluded from the study. 
data collection for the incidence study ceased when 
researchers had 30 patients in the CrlPss sample (2009–
2011) and could assess the CrlPss effects. For the com-
parative analyses between the 2009–2011 and 2008 pa-
tients, the research team established a characteristic basis 
for comparison of groups: risk and resultant incidence 
of Pu. the research team extracted the group of 2008 
children who were at risk of developing Pus (n = 35) and 
compared data collected in the 2009–2011 study.  
the cumulative incidence of Pus related to support 
surfaces during the entire two study periods was calcu-
lated as number of children at risk for Pu related to sup-
port surfaces divided by the total number of children at 
risk in the sample. after this first analysis, the research 
team compared the cumulative incidence of two groups 
using a z-test for differences in proportions. 
results
a total of 30 children, 13 (43.3%) girls and 17 (56.7%) 
boys, met the study enrollment criteria and were placed 
on a CrlPss. the majority of patients were 1 month 
to 3 years old (73.3%) and had been provided con-
ventional mechanical ventilation (60%), sedation and 
drugs (50%), parenteral (73.3%) and enteral nutrition 
(63.3%), and medical devices, most commonly central 
venous catheters (93.3%), arterial catheters (66, 7%), 
and urinary catheters (73.3%). the majority were admit-
ted due to disorders of the respiratory system (40%) (see 
table 1). Patient average length of stay was 12.7 days (sd 
± 10.3 days) for a total admission time of 380 days. two 
(6.7%) patients died during the study. the CrlPss were 
used for a total of 211 days (55.5% of the patient time in 
PICu). the average length of time of CrlPss use was 7 
days (sd ± 7 days) (see table 2). 
no repositioning schedules were implemented for 19 
children (63.3%) due to their clinical instability, condi-
table 2. time of use of the special surfaces in the PICu
Type Patients Days of use
n Average SD Median (range)
Carital Neo™ 4 5 3.6 4.5 (2–29)
Carital Juve™ 26 7.3 7.4 4 (1–25)
Total 30 7 7 4 (1–25)
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tion, or state of health. 
ten (33.3%) patients already had a Pu at the time they 
joined the study. of these, nine had one lesion and one 
patient had three. seven children had nine Pus not re-
lated to medical or diagnostic devices before using the 
mattresses under evaluation; of these, six (66.6%) healed 
before the patient left the PICu. 
seven patients (23.3%) were provided a viscoelastic 
cushion specifically designed for fixing and protecting 
the head in pediatric patients (semPCare® Visco 700, 
smith & nephew, uK), and six patients (20%) were giv-
en hydrocellular heel dressings (allevyn® Heel, smith & 
nephew, uK) in addition to the study CrlPss. 
In the CrlPss group, one (3% of total patients) of 
two (6.6% of total) patients who underwent craneosyn-
ostosis developed two Pus (category 2) related to sup-
port surfaces in the operating theater, before the patient 
received the CrlPss in PICu.
only one of the 30 children developed a new Pu relat-
ed to support surfaces (CrlPss) during the study period 
(incidence: 3.3%). the child who developed a Pu was 
20 months old, weighed 10 Kg, was admitted for a non-
Hodgkin lymphoma, and already had three Pus caused 
by care equipment before joining the study. the child 
had a Braden-Q risk score of 8, and no change of posi-
tion was possible. over 14 days with the continuous and 
reactive low-pressure support surface assigned, the child 
was intubated, received parenteral and enteral nutrition, 
and venous, arterial, and urinary catheters were used. Va-
soactive and sedation drugs were administered, together 
with heel protection dressings. the new Pu developed in 
the occipital area on the ninth day, and the patient died 
15 days after admission in PICu.
Compared with the estimated group value from 2008 
(incidence: 20% of children with support surface-related 
Pus in 35 children), the current study showed a Pu inci-
dence of support surface-related Pus of 3.3%  — CrlPss 
— (confidence interval [CI] 95% = 0.08% to 17.2%), 
representing a statistically significant difference of 16.7 
points (P = 0.021) between the two data sets. 
discussion
results of this study suggest that use of the CrlPss had 
a positive impact on Pu incidence, but all comparisons to 
previous studies must be interpreted with caution. 
the use of dynamic Pmss in pediatrics is not wide-
spread; traditionally, these surfaces have been considered 
more suitable for adults. dynamic alternating Pmss in 
particular were designed to redistribute the weight of 
immobile adult patients. according to the spanish Pres-
sure ulcers and Chronic wounds (gneauPP) document 
regarding positioning and Pmss,20 adapting adult alter-
nating dynamic mattresses to children has not had the 
desired pressure-redistribution results due to the specific 
characteristics of children.
In 2004, mcCord et al21 published results of a case se-
ries involving 108 children to assess the influence of dif-
ferent risk factors and tools in Pu prevention in a PICu; 
specifically, they examined the effectiveness of a dynamic 
low-air-loss Pmss in turning mode. the authors ob-
served when these mattresses were used, many caregiv-
ers did not make postural changes, even when advised 
by vendors. moreover, the use of turning mode caused 
the occipital area of the children to pivot at the same 
point, increasing friction and shear forces. the authors 
concluded that this type of Pmss had been designed for 
adult patients and should not be used with pediatric pa-
tients because they increased the risk of Pus.
the PICu in which the current study was conducted is 
a reference center for craniosynostosis surgery. these are 
long (from 6 to 10 hours), complex operations in which 
the child’s head must be immobilized both during the 
operation and in the first few days following it, subse-
quently increasing the risk of Pus. during this study, one 
of these children developed two Pus (category 2) in the 
operating theatre, but had a positive healing evolution 
while using the CrlPss . 
the only Pu that appeared while using the CrlPss 
under evaluation developed in the occipital area. this is 
the area with the highest risk for Pu in children under 3 
years old, with the risk of Pus logically rising in the child 
at terminal phase (non-Hodgkin lymphoma disease). no 
local pressure-relieving device (eg, viscoelastic cushion) 
was applied, because clinical instability precluded any 
movement of the patient and any professional postural 
changes. according to the scientific literature14 and rec-
ommended interventions from gneauPP in its specific 
document of literature review about Pmss,20 using lo-
cal pressure-relieving devices (such as occipital cushion, 
heel support), could be an effective option to maximize 
pressure redistribution in children in the terminal phase 
of their illness. 
the current study found it advantageous to use a 
CrlPss adapted to suit the specific anthropometry of 
children. the research team observed that not having to 
reposition young patients helped facilitate maintenance 
of pediatric patients’ clinical stability (hemodynamic 
and respiratory). use of the CrlPss avoided the need 
for regular repositioning of the 19 patients with risk fac-
tors such as malnutrition, intubation, sedation, occipi-
tal edema, or skin problems related to their pathology 
(eg, bacterial meningitis). Patients (n = 11) who could 
change position were repositioned every 3 to 4 hours. In 
the study setting, the CrlPss provided a solution to the 
disagreement between healthcare staff, some who wanted 
to make postural changes and others who did not.
In 2001, Jones et al22 published the results of an obser-
vational prospective evaluation of three dynamic, alter-
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nating air Pmss used to treat 22 children admitted to the 
PICu and the cardiac rehabilitation at the royal Hospi-
tal for sick Children in edinburgh, uK. the researchers 
observed no child developed a Pu. length of dynamic 
alternating mattress use ranged from 1 to 7 days (one 
patient maximum of 46 days), which was similar to that 
in the current study where average time of CrlPss use 
was 7 days (± 7 days). the Jones et al study is limited by 
the fact that the results obtained were not compared with 
any prior control value and the patients’ risk level was 
not recorded.
other support surface options considered included 
bubble mattress pads. However, in the authors’ experi-
ence, because the cells are designed for adults’ body sur-
faces, children tend to slide along the bed or become 
lodged between the cells. this was not a problem using 
CrlPss; the designs accommodate the different body 
surfaces of each age group. no safety-related adverse 
events were observed. when the children became more 
mobile, the bed rails were raised. the support surface 
cell height allowed healthcare staff access to the children 
when the rails were raised, even though they were still 
effective in preventing falls.
according to data from the 5 million lives campaign,5 
the Children’s Healthcare Hospital of atlanta reduced 
the incidence of Pus by 59% in 2005. Preventive mea-
sures provided to high-risk pediatric patients included 
the use of dynamic alternating Pmss for adults (Kinair®, 
KCI, san antonio, tX) and children (Pedidyne® Crib, 
KCI, san antonio, tX); however, the contraindications 
(eg, lumbar fracture) restricted use of these products. In 
the current study, the CrlPss was used with children 
displaying hemodynamic and respiratory instability, 
polytrauma (skull and lower limbs), and unstable tho-
racic fractures.
neidig et al2 found that implementing a protocol 
that involved changing the head posture every 2 hours 
in postoperative pediatric patients who had undergone 
cardiac surgery reduced the incidence of Pus from 16.9% 
to 4.8%.   
an analytical, observational study conducted among 
54 healthy children of different ages by mclane et al14 
found that a dynamic low-air-loss Pmss (efica®, Pat-
mark Company, Batesville, Il) was more effective than 
a foam mattress pad alone or in combination with gel e 
donut® (Philips respironics, andover, ma) in reducing 
Pus. a limitation of this study was that the low-air-loss 
Pmss could not be used for children weighing <22.7 Kg. 
Harris et al’s23 case study of a 38-week-old child un-
der eCmo therapy who had developed Pus on a lamb-
skin surface showed that a dynamic Pmss could not be 
used to redistribute the pressure because 1) the size was 
not compatible with the heated cradles in use with the 
child and 2) the supports surfaces were radio-opaque. 
the dynamic, constant low-pressure CrlPss used in 
the current study can be placed in incubators and heated 
cradles; in addition, the surface for patients weighing 
>6 Kg can be used with adult or child-sized beds while 
maintaining pressure redistribution. during the current 
study, one of CrlPss systems was successfully used with 
two children in incubators; however, they were not in-
cluded in the study because these patients were admitted 
to a different (neonatal) ICu. 
limitations
the small sample size, limited number of support sur-
faces, and absence of a prospective control group limits 
the ability to draw definitive conclusions about the ef-
ficacy and effectiveness of these surfaces. only two sys-
tems, one for newborns and the other for children weigh-
ing >6 Kg, were provided to the facility, which meant that 
many children who qualified for study inclusion could 
not benefit from these products. the products were as-
signed when a child was at obvious risk or upon the clini-
cal judgment of the nurse responsible for assessment. For 
ethical considerations, when a CrlPss was available, it 
was assigned to the child who needed it, even if that child 
was not included in the study (eg, admission in PICu 
less than 24 hours, children older than 10 years), further 
limiting the number of available surfaces. 
another limitation influences approaches to care. Par-
ticipating nurses were trained informally by the research 
team. although the training was intended to deal only 
with the use of the Pmss under evaluation, prevention-
related topics also were discussed. the nurses knew their 
care was evaluated, which could have affected the low Pu 
incidence observed.
this study attempted to monitor the limitations asso-
ciated with the preventive measures taken with the group 
of children using CrlPss. even though 60% of the chil-
dren were not repositioned due to their individual condi-
tions, the other 40% of patients were repositioned every 
3 or 4 hours whenever possible. additional preventive 
measures were taken — ie, hyperoxygenated fatty acids 
were applied to risk areas every 8 hours, hygiene tasks 
were performed on a daily basis, and protective dressings 
were applied between the skin and the different thera-
peutic and diagnostic devices. these preventive measures 
are similar to those provided in the previous epidemio-
logical survey that was used as a benchmark/comparison. 
another possible limitation of the study was the use 
of several local pressure-management devices in certain 
high-risk anatomical locations. these measures may bias 
some of the results, but from an ethical and professional 
point of view, providing measures shown by previous 
research to possibly benefit patients (safety principle) 
is part of a clinician’s goal to ensure the best preven-
tive care. another possible limitation is that Pus caused 
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by medical devices were not considered in the analysis. 
Carefully controlled, prospective, clinical studies are 
needed to evaluate the safety, efficacy, effectiveness, and 
cost-effectiveness of these surfaces compared to standard 
care procedures and help answer remaining questions 
about optimal Pu prevention strategies in high-risk pe-
diatric patients. 
Conclusion
the use of CrlPss was prospectively evaluated in a 
group of 30 pediatric patients admitted to the PICu and 
who were at risk for developing Pus. the incidence of 
Pu development not related to the use of a medical de-
vice was low (3.3%), much lower than the rate of similar 
ulcers in a previously conducted incidence study (20%) 
at the same facility. no adverse safety-related events oc-
curred, and the surfaces were believed to be particularly 
beneficial for patients who cannot be repositioned. ad-
ditional controlled clinical studies are warranted to help 
develop evidence-based protocols of Pu prevention in 
high-risk pediatric patients. n
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